scispace - formally typeset
G

Gretchen L. Kiser

Researcher at Amersham plc

Publications -  18
Citations -  1853

Gretchen L. Kiser is an academic researcher from Amersham plc. The author has contributed to research in topics: Gene & Substantia nigra. The author has an hindex of 15, co-authored 18 publications receiving 1794 citations. Previous affiliations of Gretchen L. Kiser include California Institute of Technology & GE Healthcare.

Papers
More filters
Journal ArticleDOI

Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair.

TL;DR: It is concluded that the checkpoint in budding yeast consists of overlapping S-phase and G2-phase pathways that respond to incomplete DNA replication and/or DNA damage and cause arret of cells before mitosis.
Journal ArticleDOI

The External RNA Controls Consortium: a progress report.

TL;DR: The External RNA Controls Consortium (ERCC) is developing commonly agreed-upon and tested controls for use in expression assays, a true industry-wide standard control.
Journal ArticleDOI

Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator.

TL;DR: It is demonstrated that cytosolic domains of human CFTR are sufficient to induce inhibition of rat epithelial Na+ currents (rENaC) when coexpressed in Xenopus oocytes and stimulated with 3‐isobutyl‐1‐methylxanthine (IBMX).
Journal ArticleDOI

Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

TL;DR: Microarray analysis and integrative data mining were used to uncover pathways implicated in the progression of changes in dopaminergic neurons after MPTP administration and disclosed dysregulation of genes in three main areas related to neuronal function.
Journal ArticleDOI

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease

TL;DR: It is demonstrated that relatively few genes' expression levels can effectively distinguish between disease and control brains, and several interesting patterns of gene expression are identified that illuminate pathogenic cascades in Parkinson's disease.